215 related articles for article (PubMed ID: 4421448)
1. [Action of the sulfonylureas tolbutamide and glypentide on the lacticdehydrogenase plasma levels (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Jun; 30(2):91-6. PubMed ID: 4421448
[No Abstract] [Full Text] [Related]
2. [Inotropic effect of tolbutamide and glipentide in isolated guinea pig atria (author's transl)].
Sánchez-Casals MS; Morell-Mestre J
Rev Esp Fisiol; 1974 Dec; 30(4):273-6. PubMed ID: 4456482
[No Abstract] [Full Text] [Related]
3. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].
Haupt E; Beyer J; Schöffling K
Arzneimittelforschung; 1974 Mar; 24(0):418-25. PubMed ID: 4211557
[No Abstract] [Full Text] [Related]
4. [Inhibition of cyclic 3',5'-nucleotide phosphodiesterase by glypentide and other oral antidiabetic agents (author's transl)].
García-Rafanell J; Morell-Mestre J
Rev Esp Fisiol; 1974 Dec; 30(4):277-81. PubMed ID: 4376253
[No Abstract] [Full Text] [Related]
5. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
6. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
[No Abstract] [Full Text] [Related]
7. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
Loubatiéres A; Mariani MM; Ribes G; Alric R
Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
[No Abstract] [Full Text] [Related]
8. Changes in plasma amino acids levels and "in vivo" gluconeogenesis from alanine in rats chronically treated with sulfonylureas.
Alemany M; Palou A; Codina J; Herrera E
Diabete Metab; 1978 Sep; 4(3):181-6. PubMed ID: 101403
[No Abstract] [Full Text] [Related]
9. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
Beyer J; Cordes U; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
[No Abstract] [Full Text] [Related]
10. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
Losert W; Hoder A; Scholz C
Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
[No Abstract] [Full Text] [Related]
12. [Extrapancreatic effects of sulfonylurea compounds. I. Studies on the effect of tolbutamide and glibornuride on blood sugar, nonesterified fatty acids, glycerin, lactate and pyruvate in the pancreatectomized dog chronically treated with insulin].
Beyer J; Cordes U; Krall H; Sell G; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2167. PubMed ID: 4679246
[No Abstract] [Full Text] [Related]
13. The pharmacology of S 1702, a new highly effective oral antibiabetic drug with unusual properties. 1. Pharmacological and hypoglycaemic activity, studies in different animal species.
Duhault J; Boulanger M; Tisserand F; Bergi L
Arzneimittelforschung; 1972 Oct; 22(10):1682-5. PubMed ID: 4677056
[No Abstract] [Full Text] [Related]
14. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
Lorch E; Gey KF; Sommer P
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
[No Abstract] [Full Text] [Related]
15. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
Balant L
Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
[No Abstract] [Full Text] [Related]
16. [Differential therapy using oral antidiabetics].
Mehnert H
Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
[No Abstract] [Full Text] [Related]
17. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
Augusti KT; Kurup PA
Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
[No Abstract] [Full Text] [Related]
18. Glypentide: a new hypoglycaemic agent.
Morell J
Biochem Pharmacol; 1974 Oct; 23(20):2922-4. PubMed ID: 4429592
[No Abstract] [Full Text] [Related]
19. [Changes in blood glucose and insulin in 4 normal subjects after administration of a single dose of glipizide and glibenclamide].
Rizzi G; Isaia GC
Minerva Med; 1974 Jan; 65(1):58-9. PubMed ID: 4214132
[No Abstract] [Full Text] [Related]
20. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
[Next] [New Search]
